The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

Acorda to Buy Civitas Therapeutics, Developer of Parkinson's Treatment


(September 29, 2014) - Acorda Therapeutics Inc. plans to buy privately-held Civitas Therapeutics as the drugmaker seeks to expand into treatments for Parkinson's disease. Civitas, is currently testing an inhaler treatment, called CVT-301, which reduces tremors and reduced movement caused by Parkinson's disease. Read more…



Article Archive

back